Your browser doesn't support javascript.
loading
Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.
Villablanca, Judith G; Ji, Lingyun; Shapira-Lewinson, Adi; Marachelian, Araz; Shimada, Hiroyuki; Hawkins, Randall A; Pampaloni, Miguel; Lai, Hollie; Goodarzian, Fariba; Sposto, Richard; Park, Julie R; Matthay, Katherine K.
Afiliação
  • Villablanca JG; Department of Pediatrics, Saban Research Institute, Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Ji L; Department of Preventative Medicine Statistics, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Shapira-Lewinson A; Department of Pediatric Hematology-Oncology, The Ruth Rappaport Children's Hospital, Haifa, Israel.
  • Marachelian A; Department of Pediatrics, Saban Research Institute, Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Shimada H; Department of Pathology, Saban Research Institute, Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Hawkins RA; Department of Radiology, University of California San Francisco, San Francisco, California.
  • Pampaloni M; Department of Radiology, University of California San Francisco, San Francisco, California.
  • Lai H; Department of Pediatric Radiology, Children's Hospital Orange County, Orange, California.
  • Goodarzian F; Department of Radiology, Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • Sposto R; Department of Preventative Medicine Statistics, Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Park JR; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington.
  • Matthay KK; Department of Pediatrics, University of California San Francisco, San Francisco, California.
Pediatr Blood Cancer ; 65(5): e26940, 2018 05.
Article em En | MEDLINE | ID: mdl-29350464
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia / Neuroblastoma Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia / Neuroblastoma Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2018 Tipo de documento: Article